CATHFLO

This brand name is authorized in United States. It is also authorized in Canada.

Active ingredients

The drug CATHFLO contains one active pharmaceutical ingredient (API):

1	Alteplase UNII 1RXS4UE564 - ALTEPLASE
	Alteplase is a recombinant human tissue-type plasminogen activator, a glycoprotein, which activates plasminogen directly to plasmin. Once bound to fibrin, it is activated, inducing the conversion of plasminogen to plasmin leading to the dissolution of the fibrin clot.
	Read more about Alteplase

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CATHFLO ACTIVASE Powder for solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AD02	Alteplase	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AD Enzymes
Discover more medicines within B01AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02245859
US	FDA, National Drug Code	50242-041